EMCDDA Home
  • EN
Search

Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (viii) All 'other drugs' outpatient clients by country and by age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium2321001097988
Bulgaria141072351036374137
Czech Republic25200000909
Denmark512443123343771
Germany245277482011856620276896
Estonia:::::::::::
Ireland15742019631314116157
Greece23000000505
Spain161453735750454
France573224141555::210:
Italy204180839882420847255
Cyprus01000000101
Latvia31713601001382260
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary1331114611168068
Malta:2:::1:::2:
Netherlands101710834205491145
Austria41111100018018
Poland4625213:::2:
Portugal530412613931212549174
Romania18815319132001869195
Slovenia1::::::::::
Slovakia00000000000
Finland201110005510
Sweden203094113169069
United Kingdom6951475948362026::237:
Croatia4220000::8:
Turkey:::::::::::
Norway0327013016824
Total555846380183176697351171911762436
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013